The effect of an insulin releasing agent, BTS 67 582, on advanced glycation end product formation in vitro

Life Sciences

Volumn 64, Issue 16, 1999, Pages 1427-1434

  Simpson, Annemarie E C M ^a   Jones, Robert B ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

Advanced glycation end product; Amadori products; BTS 67 582

Indexed keywords

1,1 DIMETHYL 2 (2 MORPHOLINOPHENYL)GUANIDINE FUMARATE; ADVANCED GLYCATION END PRODUCT; AMINOGUANIDINE; ANTIDIABETIC AGENT; GLIBENCLAMIDE; GLUCOSE 6 PHOSPHATE; LYSINE; SULFONYLUREA DERIVATIVE; TOLBUTAMIDE;

ARTICLE; ASSAY; DRUG EFFECT; DRUG STRUCTURE; FLUORESCENCE ANALYSIS; GLUCOSE OXIDATION;

FERROUS COMPOUNDS; GLUCOSE; GLUCOSE-6-PHOSPHATE; GLYBURIDE; GLYCOSYLATION END PRODUCTS, ADVANCED; GUANIDINES; LYSINE; SERUM ALBUMIN, BOVINE; TOLBUTAMIDE;

EID: 0033548507     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00076-4     Document Type: Article

References (25)

1. V.A. YAYLAYA and A. HUYGHUES-DESPOINTES, Crit. Rev. Food Sci. Nutr. 34 321-369 (1994).
2. W.L. DILLS, Am. J. Clin. Nutr. 58 779S-787S (1993).
3. J.T. WU, J. Clin. Lab. Anal. 7 252-255 (1993).
4. M. BROWNLEE, H. VLASSARA, A. KOONEY, P. ULRICH and A. CERAMI, Science 232 1629-1632 (1986).
5. R.B. JONES, K. DICKINSON, D.M. ANTHONY, A.R. MARITA, C.L. KAUL and W.R. BUCKETT, Br. J. Pharmacol. 120 1135-1143 (1997).
6. C.A. SKILLMAN and P. RASKIN, Diabetes Care 20 591-596 (1997).
7. D. EDELSTEIN and M. BROWNLEE, Diabetes 41 26-29 (1992).
8. R. BUCALA, K.J. TRACEY and A. CERAMI, J. Clin. Invest. 87 432-438 (1991).
9. D.A. WILLIAMS, Biometrics 28 519-531 (1972).
10. C.W. DUNNETT and C. GOLDSMITH, Statistics in the Pharmaceutical Industry. C.R. Buncher and J-Y. Tsay (Eds), 397-434, Marcel Dekker, New York (1981).
11. P. ARMITAGE and G. BERRY, Statistical Methods in Medical Research, 282-295, Blackwell, Oxford (1987).
12. R.R. KOHN, A. CERAMI and V.M. MONNIER, Diabetes 33 57-59 (1984).
13. V.J. STEVENS, C.A. ROUZER, V.M. MONNIER and A. CERAMI, Proc. Natl. Acad. Sci. U.S.A. 75 2918-2922 (1978).
14. S. SCHNIDER and R. KOHN, J. Clin. Invest. 67 1630-1635 (1981).
15. V.M. MONNIER and A. CERAMI, Science 211 491-493 (1981).
16. M.P. VITEK, Proc. Natl. Acad. Sci. U.S.A. 91 4766-4670 (1994).
17. R.G. TILTON, K. CHANG, K.S. HASAN, S.R. SMITH, J.M. PETRASH, T.P. MISKO, W.M MOORE, M.G. CURRIE, J.A. CORBETT, M.L. McDANIEL and J.R. WILLIAMSON, Diabetes 42 221-232 (1993).
18. J.R. REQUENA, P. VIDAL and J. CABEZAS-CERRATO, Diabet. Res. Clin. Proc. 19 23-30 (1993).
19. V.M. MONNIER, V. VISHWANATH, K.E. FRANK, C.A. ELMETS and R.R KOHN, N. Engl. J. Med. 314 403-408 (1986).
20. M.C. WELLS-KNECHT, S.R. THORPE and J.W. BAYNES, Biochem. 34 15134-15141 (1995).
21. S.P. WOLFF and R.T. DEAN, Biochem. J. 245 243-250 (1987).
22. J.V. HUNT, R.T. DEAN and S.P. WOLFF, Biochem. J. 256 205-212 (1988).
23. T.J. LYONS, K.E. BAILIE, D.G. DYER, J.A. DUNN and J.W. BAYNES, J. Clin. Invest. 871910-1915 (1991).
24. M.A. GLOMB and V.M. MONNIER, J. Biol. Chem. 270 10017-10026 (1995).
25. S.R. THORPE and J.W. BAYNES, Drugs & Aging 9 69-77 (1996).